$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification Platform

News   Sep 21, 2017 | Original story from ChromaTan

 
$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification Platform

CCTC Process Development System. Credit: ChromaTan

 
 
 

RELATED ARTICLES

Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug Discovery

News

Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.

READ MORE

Crystal Structure of Neuropeptide 1 Receptor Solved, Providing Therapeutic Angle For Obesity Treatment

News

An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.

READ MORE

Deficiency of Innate Immune Adaptor TRIF Linked to Neurodegeneration

News

Research has revealed that deficiency of the innate immune adaptor TRIF, which is essential for certain Toll-like receptor signaling cascades, significantly shortened survival time of ALS mice.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE